key: cord-0708783-svf4kcvw
authors: Sun, Maowen; Yu, Shaoxiong; Ge, Hailiang; Wang, Tao; Li, Yongfeng; Zhou, Pingping; Pan, Li; Han, Yu; Yang, Yuying; Sun, Yuan; Li, Su; Li, Lian-Feng; Qiu, Hua-Ji
title: The A137R Protein of African Swine Fever Virus Inhibits Type I Interferon Production via the Autophagy-Mediated Lysosomal Degradation of TBK1
date: 2022-04-12
journal: Journal of virology
DOI: 10.1128/jvi.01957-21
sha: e46855a552b5f475e51dce8048f60bcfb2d7eaec
doc_id: 708783
cord_uid: svf4kcvw

African swine fever is a lethal hemorrhagic disease of pigs caused by African swine fever virus (ASFV), which greatly threatens the pig industry in many countries. Deletion of virulence-associated genes to develop live attenuated ASF vaccines is considered to be a promising strategy. A recent study has revealed that the A137R gene deletion results in ASFV attenuation, but the underlying mechanism remains unknown. To elucidate the mechanism of the A137R gene regulating ASFV virulence, an ASFV mutant with the A137R gene deleted (ASFV-ΔA137R) was generated based on the wild-type ASFV HLJ/2018 strain (ASFV-WT). Using transcriptome sequencing analysis, we found that ASFV-ΔA137R induced higher type I interferon (IFN) production in primary porcine alveolar macrophages (PAMs) than did ASFV-WT. Overexpression of the A137R protein (pA137R) inhibited the activation of IFN-β or IFN-stimulated response element. Mechanistically, pA137R interacts with TANK-binding kinase 1 (TBK1) and promotes the autophagy-mediated lysosomal degradation of TBK1, which blocks the nuclear translocation of interferon regulator factor 3, leading to decreased type I IFN production. Taken together, our findings clarify that pA137R negatively regulates the cGAS-STING-mediated IFN-β signaling pathway via the autophagy-mediated lysosomal degradation of TBK1, which highlights the involvement of pA137R regulating ASFV virulence. IMPORTANCE African swine fever (ASF) is a lethal viral disease of pigs caused by African swine fever virus (ASFV). No commercial vaccines and antiviral treatments are available for the prevention and control of the disease. Several virulence-associated genes of ASFV have been identified, but the underlying attenuation mechanisms are not clear. Compared with the virulent parental ASFV, the A137R gene-deleted ASFV mutant promoted the expression of type I interferon (IFN) in primary porcine alveolar macrophages. Further analysis indicated that the A137R protein negatively regulated the cGAS-STING-mediated IFN-β signaling pathway through targeting TANK-binding kinase 1 (TBK1) for autophagy-mediated lysosomal degradation. This study not only facilitates the understanding of ASFV immunoevasion strategies, but also provides new clues to the development of live attenuated ASF vaccines.

infected with either ASFV-DA137R or ASFV-WT. To determine the expected deletion of the A137R gene, the genome of ASFV-DA137R was analyzed by next-generation sequencing (NGS). Compared with the parental ASFV-WT, no undesirable variations were found in the genome of ASFV-DA137R, except a 391-bp deletion of the A137R gene replaced by the p72EGFP expression cassette. We then analyzed the effect of the A137R gene deletion on viral growth in vitro. PAMs were infected with ASFV-DA137R or ASFV-WT at a multiplicity of infection (MOI) of 0.01, and the viral titers were assayed by 50% hemadsorption doses (HAD 50 ) at the indicated time points. The growth profile of ASFV-DA137R was similar to that of ASFV-WT in PAMs (Fig. 1C) .

The virulence of ASFV depends on the viral replication efficiency in target cells or the blockage of the immune responses by viral proteins. Since the A137R gene deletion does not influence the replication of ASFV-WT in vitro, we thus systemically analyzed the DEGs of the PAMs infected with ASFV-DA137R or ASFV-WT (MOI = 1) by RNA-seq analysis. Compared with the ASFV-WT-infected PAMs, the transcription levels of 2,458, 3,676, and 1,671 genes were altered upon ASFV-DA137R infection at 4, 12, and 20 hours post-infection (hpi), respectively (Fig. 1D) . Notably, ASFV-DA137R infection induced higher type I IFN production in PAMs at 12 and 20 hpi, including IFN-A, IFN-b, and IFNv, than did ASFV-WT (Fig. 1E ). The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the upregulated genes upon ASFV-DA137R infection were involved in the IFN signaling pathway, such as cytosolic DNA-sensing, JAK-STAT, and Toll-like receptor (TLR) signaling pathways (Fig. 1F) .

To verify the roles of pA137R regulation of the IFN signaling pathway, the transcription level of IFN-b was examined by reverse transcription-quantitative PCR (RT-qPCR) in the ASFV-DA137R-or ASFV-WT-infected PAMs. As shown in Fig. 2A , ASFV-DA137R, but not ASFV-WT, significantly enhanced IFN-b transcription in the PAMs at 12 to 20 hpi but not at 4 hpi, which was consistent with the RNA-seq analysis. Sendai virus (SeV), an IFN agonist, activates the retinoic acid inducible gene (RIG-I)-mediated IFN signaling pathway (24) . ASFV-DA137R also induced higher transcription levels of IFN-A, IFN-b, and downstream IFNstimulated genes (ISGs), including ISG54 and ISG56, in the PAMs upon SeV stimulation than did ASFV-WT ( Fig. 2B to E). Taken together, these data indicate that pA137R inhibits the IFN signaling pathway and plays an important role in evading innate immune response.

pA137R inhibits the cGAS-STING-mediated IFN-b signaling pathway. The cGAS-STING-mediated IFN-b signaling pathway is significantly suppressed upon the virulent ASFV Armenia/07 infection, but the viral proteins involved remain elusive (5) . The RNAseq analysis revealed that the cytosolic DNA-sensing signaling pathway was activated in the ASFV-DA137R-infected PAMs, and thus we further investigated the effects of pA137R on the cGAS-STING pathway. Human embryonic kidney (HEK293T) cells were cotransfected with p3ÂFlag-cGAS and -STING and reporter plasmids, along with pMyc-A137R or pCMV-Myc, for 24 h. The results indicated that overexpression of pA137R significantly inhibited the activation of the IFN-b or IFN-stimulated response element (ISRE) promoter in a dose-dependent manner ( Fig. 3A and B) . Similarly, pA137R also markedly suppressed the transcription levels of IFN-b, ISG54, and ISG56 (Fig. 3C) . These data suggest that pA137R negatively regulates the cGAS-STING-mediated IFN-b signaling pathway.

pA137R inhibits the IFN-b signaling pathway through targeting TBK1. To identify which adaptors in the cGAS-STING pathway were antagonized by pA137R, HEK293T cells were cotransfected with pMyc-A137R and reporter plasmids along with p3ÂFlag-cGAS, -STING, -TBK1, or -IRF3-5D (the active form of IRF3), respectively. We showed that pA137R markedly suppressed the activation of the IFN-b promoter induced by cGAS, STING, or TBK1, but not IRF3-5D (Fig. 4A to D) . Therefore, we speculated that pA137R may inhibit the activation of the IFN-b promoter through targeting TBK1. Glutathione S-transferase (GST) pulldown assay indicated that pA137R specifically interacted with TBK1 but not with other adaptors, including cGAS, STING, or IRF3, of the cGAS-STING pathway (Fig. 5A ). The colocalization of pA137R with TBK1 was observed in the cytoplasm, with a colocalization coefficient of 0.74 (Fig. 5B ). PAMs were infected with ASFV-WT for 48 h, and the endogenous TBK1 was subjected to coimmunoprecipitation (co-IP) assay using anti-pA137R polyclonal antibodies (PAbs). As shown in Fig. 5C , TBK1 was precipitated by pA137R in the ASFV-infected PAMs. The colocalization of pA137R and TBK1 (a colocalization coefficient of 0.75) was further demonstrated by laser confocal microscopy (Fig. 5D ). Collectively, these results indicate that pA137R blocks the IFN-b signaling pathway by interacting with TBK1.

pA137R promotes the autophagy-mediated lysosomal degradation of TBK1. Previous studies have revealed that the IFN signaling pathway is antagonized by several viruses, including human cytomegalovirus (HCMV) (25) , Zika virus (ZIKV) (26) , and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (27), through targeting or degrading the host proteins. Since pA137R interacts with TBK1 and inhibits the activation of IFN-b ( Fig. 3 to 5), we investigated the effects of pA137R on the transcription and expression of TBK1. p3ÂFlag-TBK1 and pMyc-A137R were cotransfected into HEK293T cells. The results showed that TBK1 protein expression was inhibited by overexpression of pA137R in a dose-dependent manner, while the mRNA level of TBK1 remained unchanged ( Fig. 6A and B) , indicating that pA137R may degrade the TBK1 protein. We further analyzed the TBK1 expression in the PAMs infected with ASFV-DA137R or ASFV-WT at 24 hpi. We found that ASFV-WT downregulated the expression , and p3ÂFlag-cGAS (0.01 mg) and -STING (0.05 mg), along with pMyc-A137R (0.1, 0.25, or 0.5 mg) for 24 h followed by luciferase reporter assay. The expression of cGAS, STING, or pA137R was analyzed by Western blotting using mouse anti-Flag or -Myc monoclonal antibody. GAPDH was used as a loading control. (C) pA137R inhibits the mRNA levels of IFN-b and IFNstimulated genes (ISGs). HEK293T cells were cotransfected with p3ÂFlag-cGAS and -STING along with pMyc-A137R (0.5 mg) or pCMV-Myc (0.5 mg) for 24 h, and the mRNA levels of IFN-b, ISG54, and ISG56 were quantified by reverse transcription-quantitative PCR. Error bars denote standard errors of the means. All the data were analyzed using Student's t test: **, P , 0.01; ***, P , 0.001. of TBK1, while the TBK1 expression was significantly increased upon ASFV-DA137R infection in PAMs, although it was lower than that in the uninfected PAMs (Fig. 6C ). Degradation of cellular proteins mainly relies on the ubiquitin-proteasome, autophagosome, or lysosome pathway. Therefore, HEK293T cells were cotransfected with p3ÂFlag-TBK1 and pMyc-A137R for 24 h and then treated with proteasome inhibitor MG132, autophagosome inhibitor 3-methyladenine (3-MA), or lysosomal inhibitor bafilomycin A1 (BafA1), respectively, for 8 h. None of the inhibitors affected the viability of HEK293T cells (Fig. 6D) , and the pA137Rmediated TBK1 degradation was inhibited by BafA1 or 3-MA, but not MG132 (Fig. 6E ). Since autophagy-related protein 5 (ATG5) is essential for autophagosome formation (28), we therefore examined the involvement of autophagosome in the degradation of TBK1 by , along with pMyc-A137R or pCMV-Myc, and the luciferase activities were measured at 24 hours post-infection. The expression of cGAS, STING, TBK1, IRF3-5D, or pA137R was analyzed by Western blotting using mouse anti-Flag or -Myc monoclonal antibody. GAPDH was used as a loading control. Error bars denote standard errors of the means. All the data were analyzed using Student's t test: ***, P , 0.001; ns, not significant. pA137R using the ATG5-knockout HeLa cells. Consistent with the inhibitor treatment assay, the degradation of TBK1 by pA137R was counteracted in the ATG5-knockout HeLa cells compared with the parental wild-type (WT) cells (Fig. 6F) . Altogether, these results indicate that the autophagy-mediated lysosomal pathway is responsible for the degradation of TBK1 by pA137R.

pA137R blocks the nuclear translocation of IRF3. With the activation of the cGAS-STING pathway, the activated IRF3 is translocated into the nucleus and triggers IFN-b transcription. Since IRF3 is activated by TBK1, we speculated that TBK1 degradation may influence IRF3 translocation from the cytoplasm into the nucleus. HEK293T cells were transfected with pMyc-A137R or pCMV-Myc for 24 h and then stimulated FIG 5 The A137R protein (pA137R) interacts with TBK1. (A) HEK293T cells were transfected with p3ÂFlag-cGAS, -STING, -TBK1, or -IRF3 for 48 h and lysed with NP-40 buffer. The purified GST or GST-pA137R protein was used to pull down the key adaptors of the cGAS-STING pathway in the lysates and analyzed by Western blotting using mouse anti-GST or -Flag monoclonal antibody (MAb). (B) HEK293T cells were cotransfected with p3ÂFlag-TBK1 and pMyc-A137R for 24 h and then incubated with rabbit anti-Flag or mouse anti-Myc MAb and Alexa Fluor 488 (green)-or 633 (red)-conjugated secondary antibody, respectively. Cell nuclei (blue) were stained with 49,6-diamidino-2-phenylindole (DAPI). Bars, 10 mm. (C) Primary porcine alveolar macrophages (PAMs) were infected with the wild-type ASFV HLJ/2018 strain (ASFV-WT) at a multiplicity of infection (MOI) of 1 for a coimmunoprecipitation assay. The lysates were collected at 48 hours post-infection and incubated with protein G agarose, along with rabbit anti-pA137R polyclonal antibodies (PAbs) or irrelevant rabbit immunoglobulin G (IgG), and then the bound proteins were analyzed by Western blotting using in-house mouse anti-pA137R or rabbit anti-TBK1 PAbs. (D) PAMs were uninfected or infected with ASFV-WT for 24 h at an MOI of 1, and the localization of pA137R and TBK1 was visualized by laser confocal microscopy using in-house mouse anti-pA137R or rabbit anti-TBK1 PAbs and the indicated secondary antibody, respectively. Cell nuclei (blue) were stained with DAPI as described above. Bars, 10 mm. , respectively. The expression of TBK1 or pA137R was analyzed as described above. GAPDH was used as a loading control. (F) pMyc-A137R and p3ÂFlag-TBK1 were cotransfected into autophagy-related protein 5 (ATG5)-knockout or wild-type (WT) HeLa cells for 36 h, and the expression of TBK1 or pA137R was examined with the indicated antibodies as described above. GAPDH was used as a loading control. Error bars denote standard errors of the means. All the data were analyzed using Student's t test. ns, not significant.

with SeV or poly(dA-dT). The subcellular localization of IRF3 in the absence or presence of pA137R was determined by laser confocal microscopy ( Fig. 7A and B) . In the unstimulated group, the IRF3 was mainly located in the cytoplasm. Upon SeV or poly(dA-dT) stimulation, approximately 30 to 40% of IRF3 translocated into the nucleus in the pCMV-Myc-transfected cells. However, only 10% of IRF3 was detected in the nucleus when there was ectopic expression of pA137R. Thus, pA137R degrades TBK1, leading to blockage of the nuclear translocation of IRF3.

Previous studies have shown that knocking out the immunoregulatory genes usually alters ASFV virulence (8-11, 17, 29-31) . pA137R is a late-expressed viral structural protein and associated with ASFV virulence (20, 32) , but the underlying attenuation mechanism is not clear. In this study, we found that ASFV-DA137R significantly increased type I IFN production in PAMs compared with ASFV-WT ( Fig. 1 and 2) . pA137R suppressed the cGAS-STING-mediated IFN-b signaling pathway through targeting TBK1 (Fig. 3 and 4) . Furthermore, we demonstrated that pA137R interacts with TBK1, promotes its degradation via the autophagy-mediated lysosomal pathway, and affects IRF3 nuclear translocation to block type I IFN production (Fig. 8) . To our knowledge, this is the first study to elaborate the mechanism of pA137R regulation of ASFV virulence.

TBK1 undergoes autophosphorylation and ubiquitination to facilitate the activation of downstream adaptors (e.g., IRF3 or NF-k B) during viral infections. However, viral proteins target TBK1 to downregulate IFN production by disrupting TBK1-associated complexes or degrading TBK1: e.g., the HCMV UL94 protein (25) , the herpes simplex virus 1 (HSV-1) US11 (33) and g34.5 (34) proteins, the foot-and-mouth disease virus L pro protein (35), the swine acute diarrhea syndrome coronavirus nucleocapsid protein (36), the heartland virus nonstructural proteins (37) , and the SARS-CoV-2 M protein (38) . In this study, we found that type I IFN production was inhibited by pA137R in PAMs upon ASFV infection ( Fig. 1 and 2) , and the TBK1 expression was also downregulated in the HEK293T cells with pA137R-overexpressed or ASFV-WT-infected PAMs (Fig. 6) . TBK1, a critical adaptor of the cGAS-, RIG-I-, and melanoma differentiation-associated antigen 5 (MDA-5)-mediated signaling pathways (39) , is degraded by ubiquitin-specific protease 38 (USP38) (40), major vault protein (MVP) (41) , and dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) (42) via the proteasomal or autophagy-mediated lysosomal pathway. It has been revealed that the ASFV DP96R protein degrades TBK1 (14) , but the underlying mechanism remains unknown. We have demonstrated that pA137R interacts with and degrades TBK1 via the autophagy-mediated lysosomal pathway (Fig. 5 and 6 ). The expression of TBK1 in the ASFV-DA137R-infected PAMs was higher than that in the ASFV-WT-infected PAMs but lower than that in the uninfected PAMs, implying that other ASFV proteins besides pA137R might also degrade TBK1. (47) to trigger the activation of the IFN signaling pathway. To evade innate immune responses, pA137R interacts with and degrades TBK1 via the autophagy-mediated lysosomal pathway, followed by the inhibition of IRF3 nuclear translocation to suppress the IFN-b production upon ASFV infection.

Vaccinia virus (VACV) replicates in the cytoplasm and generates dsRNA (43) . The A52 (44), K7 (45) , and E3 (46) proteins of VACV inhibit the TLR-mediated NF-k B activation. Similarly, ASFV (13, 47, 48) and HSV-1 (49, 50) also regulate the dsDNA or dsRNA-mediated antiviral responses. In this study, we found that ASFV-DA137R induced higher transcription of the IFN genes and ISGs in the PAMs upon SeV stimulation than did ASFV-WT, and pA137R negatively regulated the cGAS-STING-mediated IFN-b signaling pathway ( Fig. 2 and 3) , which indicated that pA137R is an IFN antagonist in the dsDNA (cGAS)-or dsRNA (RIG-I or MDA-5)-mediated IFN-b signaling pathway. RNA-seq analysis demonstrated that the JAK-STAT and TLR signaling pathways were activated, and the expression of chemokines (e.g., CCL2, CCL8, and CXCL8) and proinflammatory cytokines (e.g., interleukin-1a [IL-1a] and IL-1b) was upregulated in the ASFV-DA137R-infected PAMs at 12 to 20 hpi, implying that pA137R probably exerts multiple actions to evade the innate immune responses.

It is generally accepted that the early-expressed viral proteins play a key role in regulating IFN production, but several studies have shown that the late-expressed viral proteins are also involved in this process and associated with viral virulence. UL94, a late-expressed protein and structural component of HCMV, inhibits IFN-b production by disrupting the dimerization of MITA and recruitment of TBK1 to MITA (25, 51, 52) . The HSV-1 US11 protein interacts with RIG-I and MDA-5 and antagonizes IFN-b production (50); the herpesviral g34.5 protein prevents protein synthesis via the protein kinase R (PKR) signaling pathway or inhibits the production of IFN-b by promoting TBK1 degradation and disrupting the interaction between TBK1 and IRF3 (33, 53) . IFN-b inhibits viral infections, and low-virulence viruses in turn increase IFN-b production, such as West Nile virus (54), Japanese encephalitis virus (55) , bluetongue virus (56) , and ASFV (6) (7) (8) (9) (10) (11) . Deletion of the IFN antagonist from the virulent ASFV results in attenuation (7) (8) (9) (10) (11) . The A137R gene is associated with the virulence of ASFV (20) , its deletion resulted in more production of IFN-a, IFN-b, ISG54, and ISG56 in PAMs ( Fig. 1 and 2) .

There is an urgent need to define the determinants of ASFV virulence, which contributes to the development of treatments and vaccines. A low dose (10 2 HAD 50 ) of the A137R gene-deleted ASFV mutant (ASFV-G-DA137R) results in ASFV attenuation and offers protection against challenge with the virulent parental ASFV-G, but the ASFV-G-DA137R-inoculated pigs present high viremia titers (10 5 to 10 6 ) and shed the virus (20) . It has been reported that pA137R is highly conserved among the genotype I and II strains (20) . Because the attenuation of ASFV is relevant to the increased production of IFN (7) (8) (9) (10) (11) and ASFV-DA137R promotes IFN-b production in PAMs, we speculate that pA137R promotes the autophagy-mediated lysosomal degradation of TBK1 to negatively regulate IFN-b production and attenuate ASFV virulence. However, we cannot rule out the differences in the genetic backgrounds of virus strains, which lead to changes in phenotypes. Deletion of EP402R from the virulent BA71 strain results in attenuation, whereas the phenotype is not observed in the ASFV Georgia 2007 and HLJ/2018 strains (22, (57) (58) (59) . Deletion of DP148R from the Benin 97/1 strain leads to ASFV attenuation (60), but not the ASFV HLJ/2018 strain (59) , which was isolated in China (58) . However, the UK/CD2v-deleted ASFV strain also presents different attenuation in these strains (59, 61) .

In conclusion, our research is the first to reveal that pA137R interacts with and degrades TBK1 via the autophagy-mediated lysosomal pathway to inhibit IFN-b production. These findings enrich the understanding of immunoevasion by ASFV and the mechanism of pA137R regulation of ASFV virulence.

Cells and virus strain. PAMs were cultured in RPMI 1640 medium (catalog no. C11875500BT; Gibco) supplemented with 10% fetal bovine sera (FBS) (catalog no. 10091148; Gibco) and 2% antibiotics-antimycotics (catalog no. 15140122; Gibco) (62) . HEK293T (62), ATG5-knockout HeLa (63), or HeLa (64) cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (catalog no. D6429; Sigma-Aldrich) with 10% FBS at 37°C with 5% CO 2 . The ASFV HLJ/2018 strain (GenBank no. MK333180.1) (58) and SeV (65) were propagated as described previously.

Construction of plasmids. The A137R gene was amplified from the genomic DNA (gDNA) of ASFV-WT and cloned into the EcoRI/XhoI sites of the pCMV-Myc (Clontech) or pGEX-6p-1 (GE Healthcare) vector, creating pMyc-A137R or pGST-A137R, respectively. The porcine cGAS, STING, TBK1, or IRF3 gene was amplified from the cDNA of PK-15 cells and cloned into the p3ÂFlag-CMV-10 vector (Sigma-Aldrich) to generate p3ÂFlag-cGAS, -STING, -TBK1, or -IRF3, respectively. p3ÂFlag-IRF3-5D harbors an active form of IRF3 with five site-directed mutations (S394A, S396A, S400A, S403A, and T405A). The promoter reporter plasmids (pIFN-b-Fluc or pISRE-Fluc) expressing the firefly luciferase (Fluc) and the internal reference reporter plasmid pTK-Rluc expressing the Renilla luciferase (Rluc) were described previously (65) . The primers for amplification of plasmids are listed in Table 1 .

Dual-luciferase reporter (DLR) assays. HEK293T cells were cotransfected with reporter plasmids (pIFN-b-Fluc or pISRE-Fluc [0.05 mg]) and pTK-Rluc (0.01 mg), along with or without the indicated expression plasmids, using X-tremeGENE HP (catalog no. 6366546001; Roche). After 24 h of transfection, the cells were washed with phosphate-buffered saline (PBS) three times. The passive lysis buffer was added for 20 min at 4°C with gentle shaking, and then the luciferase activities were determined using the DLR assay system (catalog no. E1910; Promega) according to the manufacturer's instructions. The data are represented as the ratio of Fluc to Rluc.

Generation of the ASFV-DA137R mutant. To generate the ASFV-DA137R mutant by homologous recombination, the transfer vector was constructed, which harbors the p72p72 promoter-controlled EGFP gene and the left and right homologous arms of the A137R gene that are located in nucleotides (nt) 52692 to 54570 and 54962 to 55960, respectively, of the ASFV-WT genome. The nucleotides in the genome from positions 54571 to 54961 were replaced by the p72EGFP expression cassette. Briefly, the left and right homologous arms of the A137R gene with restriction enzyme sites were amplified using the gDNA of ASFV-WT as the template, and then fused to the p72EGFP expression cassette by overlapping PCR using the primers listed in Table 1 , and the resulting fusion fragment was cloned into the pOK-12 vector. The transfer vector was sequenced and named pOK-p72-DA137R-EGFP. The ASFV-DA137R mutant was generated by homologous recombination according to the previously described methods (61) . Briefly, PAMs were seeded in 6-well plates coated with poly-L-lysine and incubated for 24 h at 37°C. The PAMs were transfected with 2 mg of transfer vector pOK-p72-DA137R-EGFP using X-tremeGENE HP for 16 h and then infected with ASFV-WT (MOI = 3). The recombinant viruses in PAMs were harvested until the EGFP expression, followed by purification using limiting dilution.

NGS. To confirm the accurate deletion of the A137R gene in the ASFV genome, the gDNA of ASFV-DA137R was extracted from the infected PAMs using the QIAamp blood mini kit (catalog no. 51104; Qiagen), and the full-length sequence of the ASFV-DA137R genome was determined by NGS as described previously (66) .

RNA-seq analysis. PAMs were infected with ASFV-DA137R or ASFV-WT at an MOI of 1. At 4, 12, and 20 hpi, the cells were used to extract total RNAs by using TRIzol reagent (catalog no. 15596026; Invitrogen) according to the manufacturer's instructions. RNA quantification and qualification were assessed using the RNA Nano 6000 assay kit of the Bioanalyzer 2100 system (Agilent Technologies, CA, USA). The mRNAs with poly(A) tails were enriched and purified from the total mRNAs by poly(T) oligonucleotide-coupled magnetic beads. RNA-seq libraries were prepared and assessed by AMPure XP system kit (Beckman Coulter, Beverly, USA) in the Agilent Bioanalyzer 2100 system. Subsequently, the RNA-seq libraries were sequenced on an Illumina Novaseq platform (Nova gene, China). KEGG enrichment analysis of DEGs was performed using Cluster Profiler (3.4.4) .

RNA extraction and RT-qPCR. The total RNAs of the cells with indicated treatment or virus infection were extracted with the Simply P total RNA extraction kit (catalog no. BSC52M1; BioFlux) and transcribed into cDNA by FastKing gDNA Dispelling RT SuperMix (catalog no. KR118-02; Tiangen). The cDNAs from HEK293T cells or PAMs were used as templates for RT-qPCR using SYBR Premix Ex Taq (catalog no. RR390B; TaKaRa) to examine the mRNA level of human IFN-b, ISG54, ISG56, or TBK1, and porcine IFN-a, IFN-b, ISG54, or ISG56, respectively. The glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) was used as an internal reference, and all the primers are listed in Table 1 .

GST pulldown assay. The GST pulldown assay was performed as described previously (65) . In brief, HEK293T cells in 6-well plates were transfected with p3ÂFlag-cGAS, -STING, -TBK1, or -IRF3 (2 mg per well) for 48 h, and then the cells were lysed and collected. Subsequently, the purified GST or GST-pA137R protein was incubated with GST-agarose (catalog no. L00206; Genscript) for 12 h and centrifuged at 4°C, and then the agarose was washed twice with cold PBS at 4°C. Next, the Flag-cGAS, -STING, -TBK1, or -IRF3 expressed in HEK293T cells was incubated with the purified GST or GST-pA137R for 4 to 6 h and washed six times with cold PBS at 4°C. Finally, the bound proteins were analyzed by Western blotting using mouse anti-GST monoclonal antibody (MAb) (1:1,000) (catalog no. K200006M; Solarbio), mouse anti-Flag MAb (1:1,000) (catalog no. AE005; ABclonal), and mouse anti-GAPDH MAb (1:1,000) (catalog no. 60004-1-Ig; Proteintech).

Co-IP assay. PAMs were infected with ASFV-WT at an MOI of 1, and the lysates were collected at 48 hpi for the co-IP assay. Protein G agarose (catalog no. 11243233001; Roche) was incubated with the lysates and rabbit anti-pA137R PAbs or a rabbit immunoglobulin G (catalog no. ab190492; Abcam) (isotype control antibody). The bound proteins were subjected to Western blotting using rabbit anti-TBK1 (catalog no. 3504S; Cell Signaling Technology) and in-house mouse anti-pA137R PAbs.

Laser confocal microscopy. HEK293T cells were cotransfected with p3ÂFlag-TBK1 and pMyc-A137R or pCMV-Myc (0.5 mg each) for 36 h and fixed in 4% paraformaldehyde (catalog no. BL539A; Biosharp) for 30 min at room temperature. After being washed twice with PBS, the cells were permeabilized in 0.15% Triton X-100 (catalog no. 1139100; BioFroxx) for 15 min at room temperature. The cells were incubated with mouse anti-Myc MAb (1:500) (catalog no. M4439-100UL; Sigma-Aldrich) or rabbit anti-Flag PAbs (1:500) for 1.5 h at 37°C. Following incubation with Alexa Fluor 633-conjugated goat anti-mouse IgG (H1L) antibody (1:500) (catalog no. A21052; Invitrogen) or Alexa Fluor 488-conjugated donkey antirabbit IgG (H1L) antibody (1:500) (catalog no. A21206; Invitrogen) for 45 min, the cells were washed with PBS. Subsequently, the cells' nuclei were stained with 49,6-diamidino-2-phenylindole (DAPI) (1:1,000) (catalog no. D8417; Sigma-Aldrich) and observed by laser confocal microscopy (LSM880, Zeiss).

PAMs were infected with ASFV-WT (MOI = 1) for 24 h, and pA137R or TBK1 was examined with inhouse mouse anti-pA137R (1:500) or rabbit anti-TBK1 PAbs (1:100) (catalog no. 703154; Invitrogen), respectively, as described above. The colocalization coefficients were determined using the ImageJ software.

Cell viability assay. Cell viability was determined by Cell Counting Kit-8 (catalog no. K1018; APExBIO) according to the manufacturer's instructions.

Inhibitor treatment assay. HEK293T cells were cotransfected p3ÂFlag-TBK1 with pMyc-A137R or pCMV-Myc for 24 h. Then the cells were treated with 20 mM proteasome inhibitor MG132 (catalog no. M8699-1MG; Sigma-Aldrich), 10 mM autophagosome inhibitor 3-MA (catalog no. HY-19312; Medchemexpress), or 100 nM BafA1 (catalog no. HY-100558; Medchemexpress) for 8 h, and the lysates were examined by Western blotting analysis.

Nuclear translocation assay. HEK293T cells were transfected with pMyc-A137R or pCMV-Myc (0.5 mg per well) for 24 h and then stimulated with SeV (MOI = 1) or poly(dA-dT) (2 mg/mL) for 8 h. The localization of IRF3 and pA137R was examined by laser confocal microscopy using rabbit anti-IRF3 PAbs (1:100) (catalog no. 11312-1-AP; Proteintech) and mouse anti-Myc MAb (1:500), respectivel, as described above.

Statistical analysis. All data were determined in triplicates and analyzed with SPSS 22.0 software (SPSS Software, Inc.). Student's t test was used to assess statistical significance. A P value of ,0.05 was considered as significant.

Emergence of African swine fever in China

African swine fever virus: a review

Development of vaccines against African swine fever virus

African swine fever virus evasion of host defences

African swine fever virus replication and genomics

African swine fever virus Armenia/07 virulent strain controls interferon beta production through the cGAS-STING pathway

African swine fever virus Georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus

Deletion of African swine fever virus interferon inhibitors from the genome of a virulent isolate reduces virulence in domestic pigs and induces a protective response

African swine fever virus MGF-505-7R negatively regulates cGAS-STING-mediated signaling pathway

2021. pMGF505-7R determines pathogenicity of African swine fever virus infection by inhibiting IL-1b and type I IFN production

African swine fever virus protein MGF-505-7R promotes virulence and pathogenesis by inhibiting JAK1-and JAK2-mediated signaling

Identification and utility of innate immune system evasion mechanisms of ASFV

A novel TLR3 inhibitor encoded by African swine fever virus (ASFV)

Inhibition of cGAS-STING-TBK1 signaling pathway by DP96R of ASFV China 2018/1

African swine fever virus MGF360-12L inhibits type I interferon production by blocking the interaction of importin a and NF-k B signaling pathway

African swine fever virus MGF505-11R inhibits type I interferon production by negatively regulating the cGAS-STING-mediated signaling pathway

African swine fever virus multigene family 360 and 530 genes affect host interferon response

African swine fever virus E120R protein inhibits interferon beta production by interacting with IRF3 to block its activation

Deletion of E184L, a putative DIVA target from the pandemic strain of African swine fever virus, produces a reduction in virulence and protection against virulent challenge

Deletion of A137R gene from the pandemic strain of African swine fever virus is attenuated and offers protection against virulent pandemic virus

Growth kinetics and protective efficacy of attenuated ASFV strain Congo with deletion of the EP402 gene

BA71DCD2: a new recombinant live attenuated African swine fever virus with cross-protective capabilities

Development of a highly effective African swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic Eurasia strain

RIG-I detects viral genomic RNA during negative-strand RNA virus infection

Human cytomegalovirus protein UL94 targets MITA to evade the antiviral immune response

Zika virus targets human STAT2 to inhibit type I interferon signaling

Potential SARS-CoV-2 immune correlates of protection in infection and vaccine immunization

Autophagosome formation in mammalian cells

Deletion of the gene for the type I interferon inhibitor I329L from the attenuated African swine fever virus OURT88/3 strain reduces protection induced in pigs

A QP509L/QP383R-deleted African swine fever virus is highly attenuated in swine but does not confer protection against parental virus challenge

ASFV bearing an I226R gene-deletion elicits a robust immunity in pigs to African swine fever

A proteomic atlas of the African swine fever virus particle

Herpes simplex virus 1 inhibits TANKbinding kinase 1 through formation of the US11-HSP90 complex

Control of TANK-binding kinase 1-mediated signaling by the gamma (1)34.5 protein of herpes simplex virus 1

Dissecting distinct proteolytic activities of FMDV L pro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression

Swine acute diarrhea syndrome coronavirus nucleocapsid protein antagonizes interferonb production via blocking the interaction between TRAF3 and TBK1

Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 factor interaction and signaling required for interferon induction

SARS-CoV-2 membrane protein inhibits type I interferon production through ubiquitin-mediated degradation of TBK1

TBK1, a central kinase in innate immune sensing of nucleic acids and beyond

USP38 inhibits type I interferon signaling by editing TBK1 ubiquitination through NLRP4 signalosome

Zebrafish MVP recruits and degrades TBK1 to suppress IFN production

DYRK2 negatively regulates type I interferon induction by promoting TBK1 degradation via ser527 phosphorylation

Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses

IRAK-2 participates in multiple Toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination

Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation

Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses

African swine fever virus I267L acts as an important virulence factor by inhibiting RNA polymerase III-RIG-I-mediated innate immunity

African swine fever virus MGF360-14L negatively regulates type I interferon signaling by targeting IRF3

Herpes simplex virus type 1 infection disturbs the mitochondrial network, leading to type I interferon production through the RNA polymerase III/RIG-I pathway

Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5

The human cytomegalovirus (HCMV) tegument protein UL94 is essential for secondary envelopment of HCMV virions

The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegumentassociated virion protein that is expressed with true late kinetics

A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function

Beta interferon controls West Nile virus infection and pathogenesis in mice

Japanese encephalitis virus NS19 protein antagonizes interferon beta production

Bluetongue virus NS4 protein is an interferon antagonist and a determinant of virus virulence

Deletion of CD2-like gene from the genome of African swine fever virus strain Georgia does not attenuate virulence in swine

Replication and virulence in pigs of the first African swine fever virus isolated in China

A seven-genedeleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs

Deletion of the African swine fever virus gene DP148R does not reduce virus replication in culture but reduces virus virulence in pigs and induces high levels of protection against challenge

Generation and evaluation of an African swine fever virus mutant with deletion of the CD2v and UK genes

Adaptation of African swine fever virus to HEK293T cells

GABARAPL2 is critical for growth restriction of Toxoplasma gondii in HeLa cells treated with gamma interferon

Human hemoglobin subunit beta functions as a pleiotropic regulator of RIG-I/MDA5-mediated antiviral innate immune responses

Guanylate-binding protein 1, an interferon-induced GTPase, exerts an antiviral activity against classical swine fever virus depending on its GTPase activity

Deletion of the H240R gene of African swine fever virus decreases infectious progeny virus production due to aberrant virion morphogenesis and enhances the inflammatory cytokines expression in porcine macrophages

We are grateful to Honglin Jia (Harbin Veterinary Research Institute, China) for providing the ATG5-knockout HeLa cells.This work was funded by the National Natural Science Foundation of China (grants U20A2060, 32072855, 32072854, and 32072866) and the Natural Science Foundation of Heilongjiang Province (grants YQ2020C025 and JQ2020C002).